C. Busemann

发表

Gemcitabine and Docetaxel for Epithelioid Sarcoma: Results from a Retrospective, Multi-Institutional Analysis

P. Reichardt, G. Ehninger, S. Gerdes, 2014, Oncology.

Composition of molecular cardiolipin species correlates with proliferation of lymphocytes

R. Walther, C. Schmidt, U. Lendeckel, 2012, Experimental biology and medicine.

Allogeneic stem cell transplantation in patients above 55: suggestion for a further stratification of the HCT-CI

W. Krüger, C. Busemann, C. Späth, 2014, Journal of Cancer Research and Clinical Oncology.

Accelerated Allogeneic Haemopoietic Engraftment after Preceding Rituximab-Therapy

G. Dölken, W. Krüger, T. Kiefer, 2009 .

Submicroscopic genomic rearrangements change gene expression in T‐cell large granular lymphocyte leukemia

W. Ludwig, C. Schmidt, G. Przybylski, 2014, European journal of haematology.

Long-term follow-up of high-dose chemotherapy with autologous stem-cell transplantation and response-adapted whole-brain radiotherapy for newly diagnosed primary CNS lymphoma: results of the multicenter Ostdeutsche Studiengruppe Hamatologie und Onkologie OSHO-53 phase II study.

D. Niederwieser, M. Montemurro, C. Kessler, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Outcome of peripheral blood stem cell mobilization in advanced phases of CML is dependent on the type of chemotherapy applied

D. Huhn, A. Ganser, J. Duyster, 1998, Annals of Hematology.

Alternative diagnosis to heparin-induced thrombocytopenia in two critically ill patients despite a positive PF4/heparin-antibody test

A. Greinacher, S. Friesecke, T. Thiele, 2013, Upsala journal of medical sciences.

Treatment of splenic marginal zone lymphoma of the CNS with high-dose therapy and allogeneic stem cell transplantation

C. Schmidt, G. Dölken, W. Krüger, 2012, Experimental Hematology & Oncology.

Clinical course and end-of-life care in patients who have died after allogeneic stem cell transplantation

C. Schmidt, D. Pink, T. Neumann, 2017, Journal of Cancer Research and Clinical Oncology.

Efficacy of Trabectedin in Patients with Advanced or Metastatic Alveolar Soft-Part Sarcoma

P. Reichardt, D. Pink, C. Busemann, 2012, Oncology Research and Treatment.

Mucositis after Reduced Intensity Conditioning and Allogeneic Stem Cell Transplantation

G. Dölken, T. Neumann, W. Krüger, 2011, Oncology Research and Treatment.

Effects on Ara-C Cytotoxicity for AML Colony Forming Cells By Priming With rhGM-CSF and rhIL-3 In Vitro and In Vivo

W. Hiddemann, T. Büchner, B. Wörmann, 1994 .

Granulocyte-macrophage colony-stimulating factor and interleukin-3 enhance the incorporation of cytosine arabinoside into the DNA of leukemic blasts and the cytotoxic effect on clonogenic cells from patients with acute myeloid leukemia.

W. Hiddemann, T. Büchner, B. Wörmann, 1992, Seminars in oncology.

No Relapse of Calcineurin Inhibitor-Associated Thrombotic Microangiopathy after Discontinuation of Eculizumab

C. Schmidt, S. Stracke, S. Friesecke, 2017, Acta Haematologica.

Reduced platelet transfusions and earlier platelet engraftment using alemtuzumab-based conditioning regimen in allogeneic stem cell transplantation

A. Greinacher, G. Dölken, D. Pink, 2016, Journal of Cancer Research and Clinical Oncology.

Chemotherapy-induced mobilization of karyotypically normal PBSC for autografting in CML

D. Huhn, A. Ganser, S. Kreiter, 1998, Bone Marrow Transplantation.

Epstein–Barr virus reactivation after allogeneic stem cell transplantation without lymph node enlargement

G. Dölken, W. Krüger, R. Mentel, 2005, Annals of Hematology.

Facial rash mimicking cutaneous acute graft-versus-host disease after allogeneic stem cell transplantation for osteomyelofibrosis – was Demodex the culprit?

G. Dölken, W. Krüger, T. Kiefer, 2006, Bone Marrow Transplantation.

Diagnosis of toxoplasmosis in bone marrow transplant recipients: comparison of PCR-based results and immunohistochemistry

W. Siegert, J. Beyer, D. Krüger, 2000, Bone Marrow Transplantation.

Treatment of High-Risk T-NHL with Stem Cell Transplantation: A Single Center Experience

C. Schmidt, M. Evert, G. Dölken, 2015, Indian Journal of Hematology and Blood Transfusion.

Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor Increases DNA Polymerase Activity in Acute Myeloid Leukemia Blasts In Vitro and In Vivo

W. Hiddemann, C. Reuter, T. Büchner, 1992 .

Efficacy and safety of Dexrazoxane (DRZ) in sarcoma patients receiving high cumulative doses of anthracycline therapy – a retrospective study including 32 patients

P. Reichardt, G. Ehninger, S. Gerdes, 2016, BMC Cancer.

Late extramedullary relapse after allogeneic transplantation in a case of variant hairy cell leukaemia

G. Dölken, W. Krüger, T. Kiefer, 2010, Bone Marrow Transplantation.

Complete Remission and Early Relapse of Refractory Plasma Cell Leukemia after Bortezomib Induction and Consolidation by HLA-Mismatched Unrelated Allogeneic Stem Cell Transplantation

G. Dölken, W. Krüger, T. Kiefer, 2007, Oncology Research and Treatment.

Successful mobilization of PBSCs in a healthy volunteer donor by addition of plerixafor after failure of mobilization with G-CSF alone

G. Dölken, W. Krüger, T. Kiefer, 2011, Bone Marrow Transplantation.

Toxoplasmosis after allogeneic stem cell transplantation—a single centre experience

C. Schmidt, S. Ribback, F. Dombrowski, 2012, Annals of Hematology.

Low-dose alemtuzumab vs. standard policy for prevention of graft-versus-host disease in unrelated and related allogeneic stem cell transplantation—a matched pair analysis

A. Greinacher, G. Dölken, T. Neumann, 2013, Annals of Hematology.

Molecular remission of FLT3-ITD+ positive AML relapse after allo-SCT by acute GVHD in addition to sorafenib

G. Dölken, W. Krüger, T. Kiefer, 2012, Bone Marrow Transplantation.

Morphologic diagnosis of leukaemic B-lymphoproliferative disorders and the role of cyclin D1 expression

H. Stein, B. Dörken, C. Busemann, 2002, Journal of Cancer Research and Clinical Oncology.

Severe Disseminated Coagulopathy Caused by Adenocarcinoma with Bone Marrow Metastasis

A. Greinacher, G. Dölken, C. Busemann, 2013, Oncology Research and Treatment.

Doxorubicin (Doxo) and dacarbacin (DTIC) as first-line therapy for patients (pts) with locally advanced or metastatic leiomyosarcoma (LMS) and liposarcoma (LPS).

P. Reichardt, D. Pink, C. Busemann, 2011, Journal of Clinical Oncology.

Efficacy and safety of Dexrazoxane (DRZ) in sarcoma patients receiving high cumulative doses of anthracycline therapy – a retrospective study including 32 patients

P. Reichardt, G. Ehninger, S. Gerdes, 2016, BMC Cancer.